We are pleased to announce that the project entitled G4PL – Genomics for Poland, headed by Prof. Luiza Handschuh, has received funding from the European Funds for a Smart Economy (FENG) program, Action 2.4 Research Infrastructure of Modern Economy.

The consortium leader, the Institute of Bioorganic Chemistry PAS, including the Poznan Supercomputing and Networking Center, will collaborate with eleven research units:

• Institute of Human Genetics PAS

• Nencki Institute of Experimental Biology PAS

• Poznan University of Technology

• University of Warsaw

• Medical University of Bialystok

• University of Lodz

• University of Gdansk

• Jagiellonian University

• Cardinal Stefan Wyszynski National Institute of Cardiology – National Research Institute in Warsaw

• Maria Sklodowska-Curie National Research Institute of Oncology – Gliwice Branch

• Łukasiewicz Research Network – Polish Center for Technology Development.

The primary objective of the project is to establish a nationwide network of laboratories conducting research and providing services in the field of genomics, serving academic commercial  and healthcare institutions. These activities will support the development of science, personalized medicine, precise diagnostics, innovative therapies, and targeted prevention.

The network will be equipped with advanced infrastructure for genome research, including high-throughput long-read sequencing machines and a device for creating optical maps. The project will also result in the collection of new genomes, including those from patients with rare diseases, the integration and re-analysis of existing data, and their sharing within a nationwide repository. New IT tools for genome analysis will also be developed, utilizing artificial intelligence algorithms and quantum technologies.

Population genomic research contributes to a deeper understanding of genetic variation, disease prevalence, and predisposition, enabling improved diagnostics, personalized treatment, and more effective preventive measures. It also translates into tangible economic benefits, as well-targeted prevention, precise diagnostics, and personalized therapy reduce healthcare costs. The project plans to sequence samples from 6,000-7,000 donors. Some of these samples will constitute Poland’s contribution to the Genome of Europe (GoE) project.

Project value: PLN 248,337,770.24.

Project funding: PLN 180,481,656.59.

Implementation period: 2026-2029. 

The non-financial contribution to the project is made by BCODERS S.A. and Analityk Genetyka Unrug Wójtowicz Sp. k.

The project is co-financed by the European Union under the European Funds for a Smart Economy program.

 #EUFunds #EuropeanFunds 

#FunduszeUE #FunduszeEuropejskie